P3–278: The rivastigmine high‐dose, 13 mg/24h (15cm2), transdermal patch provides daily living benefits to people with severe Alzheimer's disease: Retrospective analyses of the OPtimising Transdermal Exelon In Mild‐to‐moderate Alzheimer's disease (OPTIMA) study. (1st July 2013)

Record Type:: Journal Article
Title:: P3–278: The rivastigmine high‐dose, 13 mg/24h (15cm2), transdermal patch provides daily living benefits to people with severe Alzheimer's disease: Retrospective analyses of the OPtimising Transdermal Exelon In Mild‐to‐moderate Alzheimer's disease (OPTIMA) study. (1st July 2013)
Main Title:: P3–278: The rivastigmine high‐dose, 13 mg/24h (15cm2), transdermal patch provides daily living benefits to people with severe Alzheimer's disease: Retrospective analyses of the OPtimising Transdermal Exelon In Mild‐to‐moderate Alzheimer's disease (OPTIMA) study
Authors:: Cummings, Jeffrey
Bellelli, Giuseppe
Black, Sandra
Bakchine, Serge
Krahnke, Tillmann
Strohmaier, Christine
Abstract:
Is Part Of:: Alzheimer's & dementia. Volume 9:Supplement 4S(2013)Part 16
Journal:: Alzheimer's & dementia
Issue:: Volume 9:Supplement 4S(2013)Part 16
Issue Display:: Volume 9, Issue 4, Part 16 (2013)
Year:: 2013
Volume:: 9
Issue:: 4
Part:: 16
Issue Sort Value:: 2013-0009-0004-0016
Page Start:: P658
Page End:: P658
Publication Date:: 2013-07-01
Subjects:: Alzheimer's disease -- Periodicals
Alzheimer Disease -- Periodicals
Dementia -- Periodicals
Démence
Maladie d'Alzheimer
Périodique électronique (Descripteur de forme)
Ressource Internet (Descripteur de forme)
616.83
Journal URLs:: http://www.sciencedirect.com/science/journal/15525260 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/j.jalz.2013.05.1352 ↗
Languages:: English
ISSNs:: 1552-5260
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 0806.255333
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 13297.xml